Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2697

Actual shortage: 241 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2447 (91%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

26 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-SILDENAFIL 25MG TABLET Resolved 2024-02-08 2024-03-21 218971
ACT QUETIAPINE 25MG TABLET Resolved 2024-03-18 2024-04-11 222566
TEVA-ATOMOXETINE 25MG CAPSULE Actual shortage 2024-04-05 2024-05-03 224451
TEVA-TOPIRAMATE 25MG TABLET Resolved 2024-04-11 2024-05-23 224889
TEVA-ERLOTINIB 25MG TABLET Actual shortage 2024-06-07 2024-06-07 229957
TEVA-NAPROXEN SODIUM 275MG TABLET Resolved 2021-10-21 2021-11-05 147708
TEVA-METHYLPHENIDATE ER-C 27MG TABLET (EXTENDED-RELEASE) Actual shortage 2017-11-24 2020-01-21 30685
ACT METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65993
CEFOXITIN FOR INJECTION 2G POWDER FOR SOLUTION Resolved 2017-03-17 2017-09-05 3140
CEFOXITIN FOR INJECTION 2G POWDER FOR SOLUTION Resolved 2019-06-18 2019-07-15 86969
CEFOXITIN FOR INJECTION 2G POWDER FOR SOLUTION Resolved 2019-08-22 2020-02-07 92177
AMPICILLIN SODIUM FOR INJECTION, USP 2G POWDER FOR SOLUTION Resolved 2021-07-08 2021-08-24 142189
CEFOXITIN FOR INJECTION 2G POWDER FOR SOLUTION Resolved 2021-09-30 2021-10-07 146440
AMPICILLIN SODIUM FOR INJECTION, USP 2G POWDER FOR SOLUTION Resolved 2022-06-16 2023-04-28 162846
CEFOXITIN FOR INJECTION 2G POWDER FOR SOLUTION Actual shortage 2024-06-07 2024-06-13 229942
TEVA-CYPROTERONE / ETHINYL ESTRADIOL 2MG 0.035MG TABLET Resolved 2020-04-10 2020-05-29 111857
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2019-10-03 2020-01-24 95396
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2021-05-20 2021-06-03 139725
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2021-06-03 2021-06-10 140363
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2022-08-18 2022-12-02 167203

Showing 1581 to 1600 of 2697

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64626
RATIO-ATORVASTATIN Discontinued 2018-10-19 2018-10-19 64852
ACT CLOPIDOGREL Discontinued 2018-10-19 2018-10-19 65065
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65284
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65289
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81330
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81337
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81344
HYDROCORTISONE SODIUM SUCCINATE INJECTION Discontinued 2019-04-11 2019-04-11 81347
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106136
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106139
RATIO-SALBUTAMOL Discontinued 2020-02-13 2020-02-13 106151
GEMCITABINE FOR INJECTION Discontinued 2020-02-13 2020-02-13 106155
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106170
LINEZOLID INJECTION Discontinued 2020-02-13 2020-02-13 106173
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106176
TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION 0.004% SOLUTION Discontinued 2020-01-21 2020-01-21 103788
TEVA-ECTOSONE 0.1% LOTION Discontinued 2023-12-05 2023-12-05 212526
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION 0.375G 3G POWDER FOR SOLUTION Discontinued 2023-11-15 2023-11-15 210191
RATIO-TAMSULOSIN 0.4MG CAPSULE (SUSTAINED-RELEASE) Discontinued 2018-10-19 2018-10-19 64917

Showing 21 to 40 of 250